Sansure Biotech Inc.

Sansure Biotech Inc. - PE Ratioverified

688289.SS

Price:

$16.82

Market Cap:

$9.75B

Sansure Biotech Inc., founded in Changsha, China, in 2008, is dedicated to the global development and commercialization of advanced diagnostic and research products. The company offers a diverse range of solutions, including upstream nucleic acid extraction kits, real-time PCR systems for both clinical and investigative purposes, and fluorescence detection platforms. Their extensive product portfolio encompasses diagnostic assays for critical conditions like the novel coronavirus, viral hepatitis, and AIDS. Furthermore, they provide blood screening and general extraction kits, tests for cancer-related biomarkers, and solutions for respiratory, sexually transmitted, digestive tract, prenatal,...[Read more]

Industry

Medical - Instruments & Supplies

IPO Date

2020-08-28

Stock Exchange

SHH

Ticker

688289.SS

The PE Ratio as of August 2026 (TTM) for Sansure Biotech Inc. (688289.SS) is 57.70

According to Sansure Biotech Inc.’s latest financial reports and current stock price. The company's current PE Ratio is 57.70. This represents a change of -62.73% compared to the average of 154.83 of the last 4 quarters.

Sansure Biotech Inc. (688289.SS) Historical PE Ratio (quarterly & annually)

How has 688289.SS PE Ratio performed in the past?

The mean historical PE Ratio of Sansure Biotech Inc. over the last ten years is 135.97. The current 57.70 PE Ratio has changed 4.14% with respect to the historical average. Over the past ten years (40 quarters), 688289.SS's PE Ratio was at its highest in in the September 2019 quarter at 965.76. The PE Ratio was at its lowest in in the March 2019 quarter at -19605.00.

Quarterly (TTM)
Annual

Average

135.97

Median

16.24

Minimum

0

Maximum

1.06K

Sansure Biotech Inc. (688289.SS) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Sansure Biotech Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 0%

Maximum Annual PE Ratio = 1.06K

Minimum Annual Increase = 0%

Minimum Annual PE Ratio = 0

Quarterly (TTM)
Annual
YearPE RatioChange
202555.6215.16%
202448.3055.80%
202331.00367.47%
20226.63-36.61%
202110.46-35.59%
202016.24-98.46%
20191.06KInfinity%
201800%

Sansure Biotech Inc. (688289.SS) Average PE Ratio

How has 688289.SS PE Ratio performed in the past?

The current PE Ratio of Sansure Biotech Inc. (688289.SS) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

3-year avg

44.97

5-year avg

30.40

10-year avg

135.97

Sansure Biotech Inc. (688289.SS) PE Ratio vs. Peers

How is 688289.SS’s PE Ratio compared to its peers?

Sansure Biotech Inc.’s PE Ratio is greater than Eyebright Medical Technology (Beijing) Co., Ltd. (32.19), greater than Tofflon Science and Technology Group Co., Ltd. (52.73), greater than LBX Pharmacy Chain Joint Stock Company (25.85), greater than Shanghai MicroPort Endovascular MedTech Co., Ltd. (19.32), greater than China Resources Boya Bio-pharmaceutical Group Co., Ltd. (-157200.00), greater than Autek China Inc. (22.95), greater than Hualan Biological Bacterin Inc. (57.13), greater than Mayinglong Pharmaceutical Group Co., Ltd. (16.99), greater than Xiamen Kingdomway Group Company (35.22), greater than Guobang Pharma Ltd. (13.19),

Build a custom stock screener for Sansure Biotech Inc. (688289.SS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Sansure Biotech Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Sansure Biotech Inc. (688289.SS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Sansure Biotech Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Sansure Biotech Inc.'s PE Ratio?

How is the PE Ratio calculated for Sansure Biotech Inc. (688289.SS)?

What is the highest PE Ratio for Sansure Biotech Inc. (688289.SS)?

What is the 3-year average PE Ratio for Sansure Biotech Inc. (688289.SS)?

What is the 5-year average PE Ratio for Sansure Biotech Inc. (688289.SS)?

How does the current PE Ratio for Sansure Biotech Inc. (688289.SS) compare to its historical average?